ISPOR - PSY30 Cost Utility Analysis of the Profilaxis Versus On-Demand Treatment With Recombinant Factor IX for the Treatment of Hemophilia B in Mexico

Full Text

PSY30 Cost Utility Analysis of the Profilaxis Versus On-Demand Treatment With Recombinant Factor IX for the Treatment of Hemophilia B in Mexico

Abstract

Authors

E. Muciño-Ortega V. Leyva-Bravo C. Gutiérrez R.M. Galindo-Suárez

Back to Volume 15, Issue 4

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now